DYN - Dyne Therapeutics Chief Operating Officer Trades $73K In Company Stock | Benzinga
GATTI SUSANNA HIGH, Chief Operating Officer at Dyne Therapeutics (NASDAQ:DYN), reported a large insider sell on November 2, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that HIGH sold 9,939 shares of Dyne Therapeutics. The total transaction amounted to $73,548.
Dyne Therapeutics shares are trading down 0.0% at $7.15 at the time of this writing on Friday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
Why Insider Transactions Are Important
Insider transactions shouldn't be used primarily to make an investing decision, ...